• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by DarioHealth Corp.

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care
    Get the next $DRIO alert in real time by email
    SC 13G 1 tm2431073d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

      

    SCHEDULE 13G

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

      

    DarioHealth Corp.

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    23725P209

    (CUSIP Number)

     

    November 4, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)

     

    x Rule 13d-1(c)

     

    ¨ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1.

    NAMES OF REPORTING PERSON

     

    Tasso Partners, LLC

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) x(1)

    (b) ¨

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    3,016,043(2)

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    3,016,043(2)

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    3,016,043(2)

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    7.90% (3)

    12.

    TYPE OF REPORTING PERSON

     

    OO

     

    (1)Tasso Partners, LLC owns the DarioHealth Corp. (the “Issuer”) shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera controls Tasso Capital, LLC.

     

    (2)Consists of (i) 1,394,721 shares of common stock held by the Reporting Person, (ii) shares of Preferred C Stock convertible into 1,222,772 shares of common stock, and (iii) shares of Preferred C-2 Stock convertible into 23,364 shares of common stock, which are beneficially owned by Dana Carrera is the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.

     

    (3)The percentage ownership was calculated based on a denominator which is the sum of 38,185,640 Common Stock outstanding as of the filing date of this report.

      

     

     

     

    1.

    NAMES OF REPORTING PERSON

     

    Dana Carrera

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) x(1)

    (b) ¨

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    3,016,043(2)

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    3,016,043(2)

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    3,401,043(3)

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    8.82% (4)

    12.

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)

     

    Tasso Partners, LLC owns the DarioHealth Corp. (the “Issuer”) shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera controls Tasso Capital, LLC.
    (2) Consists of (i) 1,394,721 shares of Common Stock held by the Reporting Person, (ii) shares of Preferred C Stock convertible into 1,222,772 shares of common stock, and (iii) shares of Preferred C-2 Stock convertible into 23,364 shares of common stock, which are beneficially owned by Dana Carrera is the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.
       
    (3) Consists of (i) 1,394,721 shares of Common Stock held by the Reporting Person, (iii) shares of Preferred C Stock convertible into 1,222,772 shares of common stock, (iii) shares of Preferred C-2 Stock convertible into 23,364 shares of common stock, and (iv) warrants to purchase 385,000 shares of common stock owned by GCL Family Trust (the “Trust”), which are beneficially owned by Dana Carrera, the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.

     

    (4) The percentage ownership was calculated based on a denominator which is the sum of (i) 38,185,640 shares  of common stock outstanding as of the filing date of this report, (ii) shares of Preferred C Stock convertible into 1,222,772, (iii) shares of Preferred C-2 Stock convertible into 23,364 shares of common stock, and (iv) warrants to purchase 385,000 shares of common stock, which are beneficially owned by Dana Carrera and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.

     

     

     

     

    Item 1.   Issuer
         
      (a) Name of Issuer:
         
        DarioHealth Corp.
         
      (b) Address of Issuer’s Principal Executive Offices:
         
        322 W 57TH ST. #33B NEW YORK, NY, 10019
         
    Item 2.   Filing Person
         
      (a) – (c) Name of Persons Filing; Address; Citizenship:
       

     

    This statement is filed on behalf of:

    (1)    Tasso Partners, LLC

    (2)    Dana Carrera

     

    The foregoing persons are hereinafter collectively referred to as the “Reporting Persons”. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

     

    The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

     

    The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.

     

    The principal business address of each of the Reporting Persons is:

     

    P.O. Box 503

    Rumson, NJ 07760

     

    Citizenship: Tasso Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dana Carrera is a citizen of the United States.

         
      (d) Title of Class of Securities:
         
        Common Stock, par value $0.0001 per share
         
      (e) CUSIP Number:
         
        23725P209

     

    Item 3.   If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    Not Applicable.

     

     

     

      

    Item 4.   Ownership

     

    Tasso Partners, LLC

     

      (a) Amount beneficially owned: 3,016,043 shares of common stock

     

      (b) Precent of class: 7.90%

     

      (c) Number of shares as to which such person has:

     

      (i) Sole power to vote or direct the vote: 0

     

      (ii) Shared power to vote or to direct the vote: 3,016,043

     

      (iii) Sole power to dispose or to direct the disposition of: 0

     

      (iv) Shared power to dispose or to direct the disposition of: 3,016,043

     

    Dana Carrera

     

      (a) Amount beneficially owned: 3,401,043 shares of common stock

     

      (b) Precent of class: 8.82%

     

      (c) Number of shares as to which such person has:

     

      (i) Sole power to vote or direct the vote: 0

     

      (ii) Shared power to vote or to direct the vote: 3,401,043

     

      (iii) Sole power to dispose or to direct the disposition of: 0

     

      (iv) Shared power to dispose or to direct the disposition of: 3,401,043

     

      Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☐

     

      Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

      Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not Applicable.

     

     

     

     

    Item 8.  

    Identification and Classification of Members of the Group.

     

    Tasso Partners, LLC owns the Issuer shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera is the trustee of the Trust and controls Tasso Capital, LLC.

       
    Item 9.  

    Notice of Dissolution of Group.

     

    Not applicable.

       
    Item 10.  

    Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: December 13, 2024

     

    Tasso Partners, LLC  
         
    By: /s/ Dana Carrera  
    Name:  Dana Carrera  
    Title: Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC  

      

     

    Dana Carrera  
         
    By: /s/ Dana Carrera  
    Name:  Dana Carrera  

     

     

     

     

     

     

    Get the next $DRIO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DRIO

    DatePrice TargetRatingAnalyst
    1/29/2025$2.00 → $1.00Buy → Hold
    TD Cowen
    5/13/2022$8.75Neutral → Buy
    Alliance Global Partners
    1/26/2022$28.00 → $25.00Buy
    Aegis Capital
    8/19/2021$35.00 → $28.00Buy
    Aegis Capital
    More analyst ratings

    $DRIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Franco-Yehuda Chen was granted 500,000 shares (SEC Form 4)

      4 - DarioHealth Corp. (0001533998) (Issuer)

      5/15/25 4:02:48 PM ET
      $DRIO
      Medical/Dental Instruments
      Health Care
    • SEC Form 3 filed by new insider Franco-Yehuda Chen

      3 - DarioHealth Corp. (0001533998) (Issuer)

      5/15/25 4:01:27 PM ET
      $DRIO
      Medical/Dental Instruments
      Health Care
    • New insider Leisure Lawrence B. claimed ownership of 258,000 shares (SEC Form 3)

      3 - DarioHealth Corp. (0001533998) (Issuer)

      3/7/25 4:05:19 PM ET
      $DRIO
      Medical/Dental Instruments
      Health Care